ArticleBMC microbiology2026
Antimicrobial resistance patterns and carbapenemase gene distribution in pediatric Pseudomonas aeruginosa isolates: molecular and epidemiological insights from an Iranian referral center.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAntimicrobial resistance in Pseudomonas aeruginosa represents a major challenge in pediatric healthcare, yet molecular epidemiological data from children in the Middle East are limited. This study aimed to characterize antimicrobial resistance patterns, carbapenemase gene profiles, and transmission dynamics in a tertiary pediatric hospital in Iran.
methodsWe analyzed 110 P. aeruginosa isolates from pediatric patients (December 2023-August 2024) using disk diffusion susceptibility testing, PCR detection of carbapenemase genes (blaIMP, blaKPC, blaNDM, blaOXA, blaSIM, blaSPM, and blaVIM), and RAPD-PCR genotyping. Multivariate logistic regression analysis was used to identify predictors of resistance.
resultsCarbapenem resistance (CR) affected 40.9% of isolates, with 37.3% multidrug-resistant (MDR) and 10.0% extensively drug-resistant. Among CR isolates, blaVIM (68.9%) and blaNDM (55.6%) predominated, with 49.1% harboring multiple carbapenemase genes. Age was a significant predictor of antimicrobial resistance (p < 0.05 for most antibiotics). Children < 5 years demonstrated significantly lower resistance compared to those > 10 years, with the strongest associations observed for fluoroquinolones (ciprofloxacin: AOR = 0.046 (CI: 0.010–0.212), p < 0.001; norfloxacin: AOR = 0.061 (CI: 0.013–0.283), p = 0.002) and some β-lactams (meropenem: AOR = 0.196 (CI: 0.062–0.623), p = 0.021). Gender showed no significant association with resistance across all antibiotics tested (p > 0.05). Gene coexistence was a significant predictor for β-lactams (imipenem: AOR = 1.968 (CI: 1.314–2.946), p = 0.001). RAPD-PCR revealed 23 genetic clusters, with ward-specific clustering patterns suggesting nosocomial transmission, particularly in intensive care units (ICUs).
conclusionThis study demonstrates an alarming burden of carbapenemase-producing P. aeruginosa among Iranian pediatric patients, with age-dependent antibiotic resistance, frequent co-existence of carbapenemase genes suggesting horizontal gene transfer, and ward-specific genetic clustering consistent with nosocomial transmission. These observations underscore the necessity for age-focused therapeutic strategies, intensified ICU surveillance, and targeted antimicrobial stewardship.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.